As the WP notes, the company previously reported on the temporary termination of the tests due to the fact that one of their participants suffered a stroke.
Last week, Johnson & Johnson announced the temporary suspension of tests because one of their participants was diagnosed with a certain disease. According to sources, the man suffered a stroke. An independent committee conducted an investigation and found that a new vaccine did not cause the incident.
The publication notes that the person who had a stroke was previously part of the group of subjects given an experimental vaccination. People included in the second group were given a placebo.
According to the newspaper, the stroke “could have been caused by an infection.”
The article states that the tests may resume this week. Johnson & Johnson plans to produce more than 1 billion doses of the vaccine by the end of 2021.